These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 16006139)

  • 1. Molecular targets for altering radiosensitivity: lessons from Ras as a pre-clinical and clinical model.
    Cengel KA; McKenna WG
    Crit Rev Oncol Hematol; 2005 Aug; 55(2):103-16. PubMed ID: 16006139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical target promiscuity: lessons from ras molecular trials.
    Rengan R; Cengel KA; Hahn SM
    Cancer Metastasis Rev; 2008 Sep; 27(3):403-14. PubMed ID: 18461427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibiting Ras prenylation increases the radiosensitivity of human tumor cell lines with activating mutations of ras oncogenes.
    Bernhard EJ; McKenna WG; Hamilton AD; Sebti SM; Qian Y; Wu JM; Muschel RJ
    Cancer Res; 1998 Apr; 58(8):1754-61. PubMed ID: 9563495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation sensitization by inhibition of activated Ras.
    Brunner TB; Hahn SM; McKenna WG; Bernhard EJ
    Strahlenther Onkol; 2004 Nov; 180(11):731-40. PubMed ID: 15549191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic cancer cell radiation survival and prenyltransferase inhibition: the role of K-Ras.
    Brunner TB; Cengel KA; Hahn SM; Wu J; Fraker DL; McKenna WG; Bernhard EJ
    Cancer Res; 2005 Sep; 65(18):8433-41. PubMed ID: 16166322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling inhibition with radiation in colorectal cancer: clinical trials.
    McKenna WG; Muschel RJ; Gupta A; Hahn S; Bernhard EJ
    Semin Oncol; 2003 Jun; 30(3 Suppl 6):56-67. PubMed ID: 12802796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The RAS signal transduction pathway and its role in radiation sensitivity.
    McKenna WG; Muschel RJ; Gupta AK; Hahn SM; Bernhard EJ
    Oncogene; 2003 Sep; 22(37):5866-75. PubMed ID: 12947393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting tumor cells by enhancing radiation sensitivity.
    McKenna WG; Muschel RJ
    Genes Chromosomes Cancer; 2003 Dec; 38(4):330-8. PubMed ID: 14566853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celecoxib induced tumor cell radiosensitization by inhibiting radiation induced nuclear EGFR transport and DNA-repair: a COX-2 independent mechanism.
    Dittmann KH; Mayer C; Ohneseit PA; Raju U; Andratschke NH; Milas L; Rodemann HP
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):203-12. PubMed ID: 17996386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiosensitization by SAHA in experimental colorectal carcinoma models-in vivo effects and relevance of histone acetylation status.
    Folkvord S; Ree AH; Furre T; Halvorsen T; Flatmark K
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):546-52. PubMed ID: 19427556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV protease inhibitors block Akt signaling and radiosensitize tumor cells both in vitro and in vivo.
    Gupta AK; Cerniglia GJ; Mick R; McKenna WG; Muschel RJ
    Cancer Res; 2005 Sep; 65(18):8256-65. PubMed ID: 16166302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor stimulation increases radiosensitivity of a pancreatic cancer cell line through endoplasmic reticulum stress under hypoxic conditions.
    Isohashi F; Endo H; Mukai M; Inoue T; Inoue M
    Cancer Sci; 2008 Dec; 99(12):2395-401. PubMed ID: 19018773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAS: target for cancer therapy.
    Saxena N; Lahiri SS; Hambarde S; Tripathi RP
    Cancer Invest; 2008 Nov; 26(9):948-55. PubMed ID: 18798058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Hsp90: a multitarget approach to radiosensitization.
    Camphausen K; Tofilon PJ
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4326-30. PubMed ID: 17671112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tailoring Ras-pathway--inhibitor combinations for cancer therapy.
    Blum R; Kloog Y
    Drug Resist Updat; 2005 Dec; 8(6):369-80. PubMed ID: 16356760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiosensitizing effects of the prenyltransferase inhibitor AZD3409 against RAS mutated cell lines.
    Cengel KA; Deutsch E; Stephens TC; Voong KR; Kao GD; Bernhard EJ
    Cancer Biol Ther; 2006 Sep; 5(9):1206-10. PubMed ID: 16969121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ionizing radiation up-regulates telomerase activity in cancer cell lines by post-translational mechanism via ras/phosphatidylinositol 3-kinase/Akt pathway.
    Ram R; Uziel O; Eldan O; Fenig E; Beery E; Lichtenberg S; Nordenberg Y; Lahav M
    Clin Cancer Res; 2009 Feb; 15(3):914-23. PubMed ID: 19188162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of Ras pathway signaling on tumor radiosensitivity.
    Kim IA; Fernandes AT; Gupta AK; McKenna WG; Bernhard EJ
    Cancer Metastasis Rev; 2004; 23(3-4):227-36. PubMed ID: 15197325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylation as a target for radiosensitization.
    Cerna D; Camphausen K; Tofilon PJ
    Curr Top Dev Biol; 2006; 73():173-204. PubMed ID: 16782459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation and new molecular agents, part II: targeting HDAC, HSP90, IGF-1R, PI3K, and Ras.
    Chinnaiyan P; Allen GW; Harari PM
    Semin Radiat Oncol; 2006 Jan; 16(1):59-64. PubMed ID: 16378908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.